Agilon Health (NYSE:AGL) Hits New 52-Week Low - Time to Sell?

Key Points

• 52-week low: Agilon Health shares hit a new 52-week low, trading as low as $7.48 intraday and last at $8.18 on volume of about 44,516 shares.
• Earnings miss: The company reported EPS of ($0.46) vs. consensus ($0.27) (a miss) while revenue beat at $1.57 billion, and it posted a negative ROE (120.82%) and net margin (-6.6%); analysts project -0.59 EPS for the year.
• Mixed analyst view: The consensus rating is "Hold" with a consensus price target of $54.38, but analyst opinions vary widely (three Buys, ten Holds, two Sells) and recent notes range from upgrades (Wells Fargo) to cuts (Citigroup) and a sell from Weiss Ratings.

Agilon Health, Inc. (NYSE:AGL - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $7.48 and last traded at $8.18, with a volume of 44516 shares trading hands. The stock had previously closed at $8.0350.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Wells Fargo & Company upped their price objective on shares of Agilon Health from $25.00 to $37.50 and gave the stock an "overweight" rating in a research report on Friday, February 27th. Citigroup reduced their price target on shares of Agilon Health from $21.25 to $18.75 and set a "neutral" rating for the company in a research report on Tuesday, March 3rd. Weiss Ratings reiterated a "sell (e+)" rating on shares of Agilon Health in a research note on Wednesday, January 21st. Royal Bank Of Canada raised Agilon Health from a "hold" rating to a "moderate buy" rating in a report on Wednesday, December 3rd. Finally, BTIG Research reaffirmed a "neutral" rating on shares of Agilon Health in a research note on Friday, December 12th. Three analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $54.38.

Agilon Health Trading Up 1.1%

The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a fifty day simple moving average of $0.59 and a 200-day simple moving average of $0.75. The company has a market capitalization of $3.37 billion, a PE ratio of -8.55 and a beta of 0.11.

Agilon Health (NYSE:AGL - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.19). Agilon Health had a negative return on equity of 120.82% and a negative net margin of 6.60%.The company had revenue of $1.57 billion for the quarter, compared to analysts' expectations of $1.46 billion. Analysts predict that Agilon Health, Inc. will post -0.59 EPS for the current year.

Institutional Trading of Agilon Health

Several institutional investors have recently made changes to their positions in the company. Wealthcare Advisory Partners LLC acquired a new stake in Agilon Health during the third quarter worth $26,000. LPL Financial LLC grew its holdings in shares of Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company's stock worth $30,000 after purchasing an additional 30,000 shares during the period. Krilogy Financial LLC acquired a new stake in shares of Agilon Health during the 4th quarter worth about $34,000. CIBC Bancorp USA Inc. acquired a new stake in shares of Agilon Health during the 3rd quarter worth about $34,000. Finally, Merit Financial Group LLC purchased a new stake in Agilon Health in the 4th quarter valued at about $35,000.

Agilon Health Company Profile

Agilon Health NYSE: AGL is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.